The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ARTO trial (NCT03449719), a randomized phase II trial enrolling oligometastatic castration-resistant prostate cancer patients treated with first-line abiraterone acetate with or without stereotactic body radiation therapy: Preliminary results comprehensive of biochemical outcomes and circulating tumor cells analysis.
 
Giulio Francolini
No Relationships to Disclose
 
Pietro Garlatti
No Relationships to Disclose
 
Mauro Loi
No Relationships to Disclose
 
Beatrice Detti
No Relationships to Disclose
 
Michele Aquilano
No Relationships to Disclose
 
Andrea Allegra
No Relationships to Disclose
 
Barbara Guerrieri
No Relationships to Disclose
 
Viola Salvestrini
No Relationships to Disclose
 
Pamela Pinzani
No Relationships to Disclose
 
Chiara Bellini
No Relationships to Disclose
 
Francesca Salvianti
No Relationships to Disclose
 
Giulia Stocchi
No Relationships to Disclose
 
Lucia Pia Ciccone
No Relationships to Disclose
 
Giulia Salvatore
No Relationships to Disclose
 
Mariangela Sottili
No Relationships to Disclose
 
Vanessa Di Cataldo
No Relationships to Disclose
 
Isacco Desideri
No Relationships to Disclose
 
Monica Mangoni
No Relationships to Disclose
 
Icro Meattini
No Relationships to Disclose
 
Lorenzo Livi
No Relationships to Disclose